Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01754831 · ClinicalTrials.gov registry record · Early Phase 1
Fluoride Administered and Retained After Topical Fluoride Varnish
A Early Phase 1 study, sponsored by University of Washington.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 6
- Enrollment target
NCT01754831 is a Early Phase 1 study that has completed, run by University of Washington. The registered enrollment target is 6 participants.
The verdict
NCT01754831, a Early Phase 1 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
The specific aim of the study is to determine the excess urinary fluoride and its time course after administration of an application of Premier Enamel Pro Varnish to the teeth of 12-15 month old infants. From these data the investigators can estimate the bioavailable (more precisely the equivalent) dose of sodium fluoride and the peak serum fluoride concentration that will allow an estimate of the margin of safety of the procedure.
Interventions
- DEVICE Fluoride varnish
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2011-12 |
| Est. Completion | 2013-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01754831
The ClinicalTrials.gov registry entry for NCT01754831 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fluoride varnish is the first listed.
NCT01754831 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01754831 about?
NCT01754831 is a clinical study titled "Fluoride Administered and Retained After Topical Fluoride Varnish". The specific aim of the study is to determine the excess urinary fluoride and its time course after administration of an application of Premier Enamel Pro Varnish to the teeth of 12-15 month old infants. From these data the investigators can estimate the bioavailable (more precisely the equivalent) ...
What is the current status of trial NCT01754831?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 6 participants. The study started on 2011-12. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01754831?
The interventions under investigation include: Fluoride varnish (DEVICE).
Who is sponsoring clinical trial NCT01754831?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.